Understanding Breakthrough Infections Following mRNA SARS-CoV-2 Vaccination

Michael Klompas^{1

2}

Affiliations

¹ Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts.
² Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.

Editorial

Michael Klompas. JAMA. 2021.

. 2021 Nov 23;326(20):2018-2020.

doi: 10.1001/jama.2021.19063.

Michael Klompas^{1

2}

¹ Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts.
² Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.

No abstract available

Comment on

Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity.
Tenforde MW, Self WH, Adams K, Gaglani M, Ginde AA, McNeal T, Ghamande S, Douin DJ, Talbot HK, Casey JD, Mohr NM, Zepeski A, Shapiro NI, Gibbs KW, Files DC, Hager DN, Shehu A, Prekker ME, Erickson HL, Exline MC, Gong MN, Mohamed A, Henning DJ, Steingrub JS, Peltan ID, Brown SM, Martin ET, Monto AS, Khan A, Hough CL, Busse LW, Ten Lohuis CC, Duggal A, Wilson JG, Gordon AJ, Qadir N, Chang SY, Mallow C, Rivas C, Babcock HM, Kwon JH, Halasa N, Chappell JD, Lauring AS, Grijalva CG, Rice TW, Jones ID, Stubblefield WB, Baughman A, Womack KN, Rhoads JP, Lindsell CJ, Hart KW, Zhu Y, Olson SM, Kobayashi M, Verani JR, Patel MM; Influenza and Other Viruses in the Acutely Ill (IVY) Network. Tenforde MW, et al. JAMA. 2021 Nov 23;326(20):2043-2054. doi: 10.1001/jama.2021.19499. JAMA. 2021. PMID: 34734975 Free PMC article.